Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines - Wikidata - wikimedia - TriplyDB

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

http://www.wikidata.org/entity/Q35752619

about

Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia State of the art: Oral antiplatelet therapy New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism The role of platelets in the recruitment of leukocytes during vascular disease Genotyping and phenotyping of platelet function disorders Review article: Venous thromboembolism after total joint replacement 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Low dose aspirin and pregnancy: how important is aspirin resistance?Platelets in pulmonary vascular physiology and pathology.Management of Antithrombotic Therapy for Gastroenterological Endoscopy from a Cardio-Cerebrovascular Physician's Point of View.Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults (from the National Health Interview Survey, 2012).Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.Clot strength is negatively associated with ambulatory function in patients with peripheral artery disease and intermittent claudication.Association of cyclooxygenase-2 genetic variant with cardiovascular disease.Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Patients' perception about risks and benefits of antithrombotic treatment for the prevention of venous thromboembolism (VTE) after orthopedic surgery: a qualitative study.Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery The lack of aspirin resistance in patients with coronary artery disease Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.Perioperative management of patients with rheumatic diseases Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases.Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment Models.Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel.Advances in monitoring of aspirin therapy.Review: Viral infections and mechanisms of thrombosis and bleeding.The future of inpatient anticoagulation management.Perioperative management of antiplatelet therapy in patients with drug-eluting stents.Identifying determinants of variability to tailor aspirin therapy.Indications for platelet aggregation inhibitors after venous stents.Cardiovascular pharmacology core reviews: aspirin.Updates in antiplatelet agents used in cardiovascular diseases.Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis.Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives.Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.ST elevation myocardial infarction: recent advances and updates.

P2860

Q24197847-165598FC-75C2-4BE2-A31B-AB289B726136 Q26746161-42B7CDBA-14A5-463F-A1D7-744F318F8F81 Q26786574-E32B0B32-0AB8-4533-8F56-9A3D5EF562B5 Q26801407-2D5C91CF-E2B7-4BCC-993E-3545091F2997 Q26860264-A7DE4492-6D63-4CD4-9C7A-BEF78F8AD236 Q27006824-F6E66E85-025A-4D06-9A3B-9B430BCD27CF Q27341873-6224D24E-81C9-45B6-BB2D-4B307F28C15B Q28068597-4AACAAF6-4A7B-4EFD-9AB7-354A81D4FDEC Q33404240-E4FAB133-FD80-4978-A09D-2C2580E745CE Q34036912-02BA1A3E-B7AC-4969-81B0-2CCF3F7366F6 Q35193736-459010CF-B61F-4F14-A049-7A8C50E5E033 Q35234175-4F486B1B-91F5-4B26-A947-D94872944912 Q35555531-CEFC019C-5112-405F-81F4-E19ACAFD89C0 Q35608507-7B1F41EB-6D5E-4177-9C7D-BBC7B2829FC8 Q35752615-A2222733-8180-4314-9EC4-DB70AE6CD70A Q35821912-3326A64C-E2CF-453E-9643-1A3E6EC8802F Q36020274-D7D33A2A-D0C7-436B-ABFD-FE668BF855CF Q36083225-02482F5B-4775-4D85-BD57-558CDB6E1D19 Q36298714-A58607B3-4903-4B02-96DA-365FB2D5A189 Q36691432-E776A3F2-C83D-4767-A79F-A1BC42EE5461 Q36802113-25B0FC0A-5067-46CD-8C92-947F29C8389D Q37186437-9A77C833-71DA-4A03-BB8B-BE2497755744 Q37431386-17E2F060-E7E4-41F8-9FE0-F01894026CD7 Q37454324-1EB240D4-259F-4426-A312-8F0035651A9D Q37575121-9ED541F1-9FF7-4850-8EA9-4CA7BAE8E4EC Q37591970-E9E45998-869D-4903-8E70-440FB799AB39 Q38025446-83673367-5416-45D0-922E-B1573CDA6315 Q38032895-18BE009D-1D79-4E90-AA1A-84BA596569B4 Q38038832-392AAF9D-7499-4E27-9A41-807241D4E864 Q38082467-452D6D80-5190-4C68-BF83-7ACC340300B6 Q38084549-37E17F86-9BB4-4A3E-A8B6-10FC674A2252 Q38087384-996B070F-2C34-49CD-90C5-A16EA02E6AAB Q38088604-8519CDCE-CBB4-44FF-9974-2DDAED516080 Q38140795-51FBC482-3B3A-4404-9745-F2DEA9124EF6 Q38161394-B8F62052-2736-4DD8-8086-22B46731BD94 Q38195191-DEF6AEFC-7132-4E26-98DD-5A0ED6F22287 Q38204489-E3E50716-5AC7-4E72-B1D5-4EE2A3E9AC6E Q38228898-3BB93CBB-4A70-4F49-8643-6DDBD0D2E892 Q38259405-70987648-4985-4202-9433-1683794BDDA4 Q38263602-EDE6FC43-A36A-4F77-BEC2-AA339BFE85B3

P2860

Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

http://www.wikidata.org/entity/Q35752619

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@ast

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@en

type

label

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@ast

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@en

prefLabel

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@ast

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@en

P1433

Q35752619-A39C3B51-3C42-4CFB-B9D0-899861C4A516

P1476

Q35752619-324BF571-AA65-4EEC-9D28-5A3D5F3F54B1

P2093

Q35752619-25ACCB0A-0574-4D96-B0B2-C105DC801E40

Q35752619-70A9D1FD-2468-4920-8952-447E595DFB4A

Q35752619-7473C462-2900-48AE-A227-D0B9CF23309F

Q35752619-9F5D0ADB-7764-4307-A89D-F666D731FA93

P2860

Q35752619-052BE3BB-26F5-46DA-8721-BF0EE4F2A9A1

Q35752619-063B7472-D2CA-4509-8A5A-3A600129AADB

Q35752619-08D6E790-95AC-4484-B22C-461BC00253F5

Q35752619-0C1EC2A4-1737-46BE-BCBD-53D7029048FC

Q35752619-0C57EAB1-B4E4-4D1F-B51B-440F05B1897B

Q35752619-0D15CA43-ADB8-46D9-A43E-EC86CCAFD605

Q35752619-0D40314A-BB7A-42EA-9D17-A58E861C6AEB

Q35752619-0EA0B4D3-1433-45D7-A592-EEE11F5BF209

Q35752619-0ECA6C96-13F5-491E-8F70-2A5560C0FB13

Q35752619-0F951D74-B338-4633-945B-122623BDCDD6

P304

Q35752619-BBAF02E1-94E8-4ED5-813F-E99F15EDE128

P31

Q35752619-774AC783-AC5A-4422-A0CA-C310FCA47A83

P356

Q35752619-91BF51A4-6DFC-4D11-A1BC-64BF532CE0F4

P407

Q35752619-A698D950-2454-42E1-AAB4-D65688060404

P433

Q35752619-C6BD1D36-8C03-4A63-964A-D0F973AD2A2F

P478

Q35752619-D8481893-8C6C-466E-9F29-63D9F0C6CB8A

P50

Q35752619-BD4897E9-C8B4-4DCC-A032-24B79914414F

P577

Q35752619-37546B3D-7BF4-4C3B-B060-DF40AA8670DF

P5875

Q35752619-1DA91265-630C-410B-ACFD-3C090120165E

P698

Q35752619-38F9ECEB-91BB-4E04-8CD8-D4644DB7A98B

P921

Q35752619-7EA63576-5F4A-4AC6-BF4A-7DEE0CE6C2F5

P932

Q35752619-513C6B13-5E85-45FC-8912-8101E2223FC5

P356

P1433

P1476

Antiplatelet drugs: Antithromb ...... d Clinical Practice Guidelines

@en

P2093

Frederick A Spencer

http://www.w3.org/2001/XMLSchema#string

Jack Hirsh

http://www.w3.org/2001/XMLSchema#string

Jeffrey I Weitz

http://www.w3.org/2001/XMLSchema#string

Trevor P Baglin

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Anticoagulants for acute ischaemic stroke

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease

Antiplatelet agents for preventing pre-eclampsia and its complications

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

P304

e89S-e119S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.11-2293

http://www.w3.org/2001/XMLSchema#string

P407

P433

2 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

John W. Eikelboom

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10743570

http://www.w3.org/2001/XMLSchema#string

P698

22315278

http://www.w3.org/2001/XMLSchema#string

P921

P932

3278069

http://www.w3.org/2001/XMLSchema#string